13-24321272-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_178540.5(C1QTNF9):c.506C>T(p.Thr169Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,435,270 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_178540.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QTNF9 | NM_178540.5 | c.506C>T | p.Thr169Met | missense_variant | 4/4 | ENST00000332018.5 | |
C1QTNF9 | NM_001303137.2 | c.506C>T | p.Thr169Met | missense_variant | 5/5 | ||
C1QTNF9 | NM_001303138.2 | c.506C>T | p.Thr169Met | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QTNF9 | ENST00000332018.5 | c.506C>T | p.Thr169Met | missense_variant | 4/4 | 1 | NM_178540.5 | P1 | |
C1QTNF9-AS1 | ENST00000449656.1 | n.73+254G>A | intron_variant, non_coding_transcript_variant | 5 | |||||
C1QTNF9 | ENST00000382071.6 | c.506C>T | p.Thr169Met | missense_variant | 4/4 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000198 AC: 23AN: 116336Hom.: 0 Cov.: 17
GnomAD3 exomes AF: 0.000261 AC: 43AN: 164676Hom.: 0 AF XY: 0.000239 AC XY: 21AN XY: 87958
GnomAD4 exome AF: 0.000116 AC: 153AN: 1318844Hom.: 3 Cov.: 32 AF XY: 0.000112 AC XY: 73AN XY: 652476
GnomAD4 genome AF: 0.000206 AC: 24AN: 116426Hom.: 0 Cov.: 17 AF XY: 0.000201 AC XY: 11AN XY: 54618
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at